Citius Pharmaceuticals annual capital expenditures (capex)
2017
2020
2021
2024
2025
Citius Pharmaceuticals Capital Expenditures (CapEx) Growth & History (CTXR)
Citius Pharmaceuticals's capital expenditures (capex) was $5.8M for fiscal 2025.
View full Citius Pharmaceuticals company overviewCitius Pharmaceuticals annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | $5.8M | $750,000 | +15.00% |
| 2024 | 2024-09-30 | $5.0M | — | — |
| 2021 | 2021-09-30 | $6,938 | $5,107 | +278.92% |
| 2020 | 2020-09-30 | $1,831 | — | — |
| 2017 | 2017-09-30 | $2,126 | — | — |
Citius Pharmaceuticals quarterly capital expenditures (capex)
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-03-31 | $600,000 | — | — |
| Q1 2026 | 2025-12-31 | $4.4M | — | — |
Citius Pharmaceuticals capital expenditures (capex) trends
Over the last five fiscal years, Citius Pharmaceuticals's capital expenditures (capex) increased from $1,831 to $5.8M, a change of $5.7M. The latest reported quarter, Q2 2026, shows $600,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Citius Pharmaceuticals source filings ↗